A new study of 1,001 women with ovarian cancer found that 14% of them carried a BRCA1 or BRCA2 mutation. However, 44% of those women did not have a family history of breast or ovarian cancer. The BRCA mutations can not only help evaluate risk of developing ovarian cancer, but may direct treatment and can … Continued
A new article explores the long term effects of cancer care, and the unique needs of survivors. With 18 million cancer survivors expected to be alive in the United States by 2022, this follow up care is important. It may require more education of a primary care provider and/or coordination between the oncologist and primary … Continued
Like many Partner Members of the Alliance, the Ovarian Cancer Circle/Inspired by Robin Babbini was founded in memory of a particular woman with ovarian cancer. What sets Robin apart is her age at diagnosis: 17. “Our family didn’t know the symptoms,” recalls her mother, Paulinda Babbini. “A full year passed from Robin’s earliest symptoms to … Continued
05/29/2012 In an abstract that will be presented at the American Society of Clinical Oncology annual meeting in Chicago this weekend, researchers report that in patients with platinum-sensitive recurrent serous ovarian cancer, olaparib plus paclitaxel plus carboplatin, followed by maintenance treatment with olaparib, resulted in a significant improvement in progression-free survival compared with paclitaxel plus … Continued
05/29/2012 Research that will be presented at the 2012 American Society of Clinical Oncology meeting June 1-5th suggests that obesity did not affect recurrence, time to recurrence, or progression-free survival in women with epithelial ovarian cancer following surgery and chemotherapy. Previous research examining the relationship between obesity and ovarian cancer has yielded mixed results. Click … Continued
Based on data showing that removing a woman’s fallopian tubes removes her risk of developing ovarian cancer, doctors are now urging women who are having their tubes tied to have them removed, instead. There is an increasing body of evidence suggesting that ovarian cancer may start in the fallopian tubes. Surgery to remove the fallopian … Continued
FREMONT, CA AND NEW YORK, NY – May 8, 2012 – RedCannon Security, Inc. announced today that together with Ovarian Cancer Research Fund (OCRF), they are launching a limited time (90-day) fundraising campaign to help OCRF raise up to $500K for much-needed ovarian cancer research. As part of the campaign, RedCannon will provide licenses of … Continued
In November 2006, Kay Kerbyson was diagnosed with ovarian cancer. A young mother of twins, Kay lived with her family in the small town of Los Alamos, New Mexico. She had to travel 100 miles to Albuquerque for her treatments. When her cancer recurred in January 2008, Kay wanted to talk to other ovarian cancer … Continued
Posted by Cara on May 1, 2012 The Ovarian Cancer National Alliance submitted the following comments in response to the United States Preventive Service Task Force request for comments on draft recommendations for ovarian cancer screening. The comments can be found as a pdf online. Comments to USPSTF re: Draft Reaffirmation Recommendation Statement Screening for Ovarian Cancer: U.S. Preventive Services … Continued
04/30/2012 Research published this month in the Journal of the National Cancer Institute suggests that DNA repair genes may be a predictor of ovarian cancer survival. Researchers at Dana-Farber Cancer Institute in Boston used gene expression data from The Cancer Genome Atlas database to develop a molecular “score” by looking at genes involved in … Continued
04/16/2012 Research reported in the journal PLoS Medicine finds that a woman’s Body Mass Index (BMI) and height are both tied to her risk for ovarian cancer. Regardless of a woman’s height and size, her risk of developing ovarian cancer remains very small. Researchers from the United Kingdom included data from more than 25,000 women … Continued
04/11/2012 In a draft statement released April 11, 2012, the U.S. Preventive Services Task Force (USPSTF) again stated that screening average-risk women for ovarian cancer does more harm than good. The USPSTF, an independent volunteer panel of non-government experts in prevention and evidence-based medicine, is composed of primary care providers (such as internists, pediatricians, family physicians, gynecologists/obstetricians, … Continued
Get email updates about research news, action alerts, and ways to join the fight.
